Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Squamous Cell Carcinoma (CSCC)”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07455331
What this trial is testing

Flash Radiotherapy for Skin Cancer

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)Basal Cell Carcinoma (BCC)
Jules Bordet Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT06998342
What this trial is testing

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
University of Vermont Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT06580054
What this trial is testing

Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckRecurrent Cutaneous Squamous Cell Carcinoma of the Head and NeckStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
University of Michigan Rogel Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT03833167
What this trial is testing

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Who this might be right for
Carcinoma, Squamous Cell
Merck Sharp & Dohme LLC 450
Early research (Phase 1)Study completedNCT03889912
What this trial is testing

Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinoma
Regeneron Pharmaceuticals 97
Not applicableLooking for participantsNCT06879964
What this trial is testing

Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Fondazione IRCCS Policlinico San Matteo di Pavia 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT03944941
What this trial is testing

Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer

Who this might be right for
Skin Squamous Cell CarcinomaMetastatic Skin Cancer
Alliance for Clinical Trials in Oncology 60
Testing effectiveness (Phase 2)Study completedNCT04154943
What this trial is testing

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals 79
Not applicableStudy completedNCT05493826
What this trial is testing

Real World Study on the Use of Cemiplimab in Adult Patients in UK

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Sanofi 110
Testing effectiveness (Phase 2)Ended earlyNCT04799054
What this trial is testing

TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+4 more
Ascendis Pharma Oncology Division A/S 188
Not applicableStudy completedNCT05482880
What this trial is testing

Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinomas+7 more
Maastricht University Medical Center 78
Early research (Phase 1)Looking for participantsNCT04389632
What this trial is testing

Sigvotatug Vedotin in Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer 1,006
Early research (Phase 1)Study completedNCT04160065
What this trial is testing

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaNon-Melanoma Skin Cancers
TuHURA Biosciences, Inc. 23
Testing effectiveness (Phase 2)UnknownNCT05238363
What this trial is testing

The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Shanghai Henlius Biotech 20
Not applicableApproved For MarketingNCT06132191
What this trial is testing

Expanded Access Use of Cemiplimab in Patients With Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Basal Cell Carcinoma (BCC)Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06585410
What this trial is testing

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals 369
Testing effectiveness (Phase 2)Looking for participantsNCT05377905
What this trial is testing

Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancers - Squamous Cell Carcinoma
Falo, Louis, MD 48
Large-scale testing (Phase 3)Looking for participantsNCT06692556
What this trial is testing

Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Centre Leon Berard 266
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04808999
What this trial is testing

Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)

Who this might be right for
Squamous Cell Carcinoma
Diwakar Davar 30
Load More Results